Intimation of Credit Rating

07th October, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Intimation of Credit Rating Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that India Ratings and Research Private Limited has: • Affirmed the credit rating and revised the outlook from stable to positive of the Company’s existing banking facilities, issuer rating and Non-Convertible Debentures. The rating along with outlook is IND AA+/Positive; and • Affirmed and Assigned the credit rating for the existing and proposed Commercial paper of the Company respectively at IND A1+. This is for your information and record. Thanking you, Yours Sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com